X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217022
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf
https://www.business-standard.com/companies/news/zydus-receives-final-approval-from-usfda-for-esomeprazole-magnesium-123060800613_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206055
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213699
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-5-2022-44974.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-18-2022-1653024384.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-6-2021-1609918562.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213859
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212949
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213158
https://psnc.org.uk/our-news/medicine-supply-notification-esomeprazole-40mg-iv-powder-for-solution-grunenthal-ranbaxy-tilomed/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212088
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212507
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-to-recall-1752-bottles-of-heartburn-drug-in-the-us/articleshow/75656114.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212866
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-6-2020-1588742806.pdf
https://www.biospectrumindia.com/news/43/15876/dr-reddys-laboratories-launches-delayed-release-tablets-in-the-u-s-market.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211752
https://business.medicaldialogues.in/pharma-news/dr-reddys-laboratories-launches-generic-of-naproxen-esomeprazole-magnesium-delayed-release-tablets-63539
https://www.biospace.com/article/releases/dr-reddy-s-laboratories-announces-the-first-generic-launch-of-naproxen-and-esomeprazole-magnesium-delayed-release-tablets-in-the-u-s-market/
https://www.business-standard.com/article/pti-stories/sun-pharma-gets-partial-relief-from-us-court-in-litigation-involving-three-generic-drugs-119120200818_1.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/now-antacids-must-carry-kidney-injury-warning/articleshow/71933520.cms
https://www.pharmacompass.com/pdf/news/union-quimico-farmaceutica-fails-edqm-inspection-1572404101.pdf
https://www.fiercepharma.com/manufacturing/need-a-safe-antacid-for-heartburn-fda-declares-pepcid-nexium-and-others-free-ndma
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212376
https://www.raps.org/news-and-articles/news-articles/2019/9/product-hopping-ec-hearing-addresses-restriction
https://pharmaphorum.com/news/az-says-recovery-to-continue-to-despite-patent-expiry-and-brexit-headwinds/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209716
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206296
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209495
https://www.business-standard.com/article/pti-stories/glenmark-pharma-gets-usfda-nod-for-acid-reflux-medication-119051400237_1.html
https://www.pharmaceutical-technology.com/downloads/whitepapers/materials/polpharma-finished-dosage-formulation-dossier-development/#polpharma
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204920
https://www.pharmacompass.com/pdf/news/Enforcement-Report-for-Week-of-February-20-2019-1550644123.pdf
https://www.thehindubusinessline.com/companies/zydus-cadila-gets-tentative-usfda-nod-for-generic-acid-reflux-drug/article26050807.ece
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204206
https://www.forbes.com/sites/matthewherper/2018/12/19/glaxo-and-pfizer-raise-the-question-should-drug-companies-sell-toothpaste-and-chapstick/?utm_source=newsletter&utm_medium=email&utm_campaign=innovationrx#b61045d235ed
https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM293268.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-nexium-21957-esomeprazole-magnesium-delayed-release-for-oral-suspension-1541063315.pdf
https://endpts.com/astrazeneca-hands-over-some-rights-to-nexium-vimovo-to-grunenthal-as-its-plots-turnaround/
https://www.genengnews.com/news/grunenthal-acquires-partial-rights-to-nexium-vimovo-from-astrazeneca-for-up-to-922m/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202461
Market Place
Share 
